Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $641.38 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $97.98 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $92.82 | 6 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $78.62 | 6 | $0 (2021) |
| Novo Nordisk Inc | $68.91 | 4 | $0 (2024) |
| ABBVIE INC. | $60.09 | 3 | $0 (2024) |
| Inspire Medical Systems, Inc. | $53.82 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $41.81 | 3 | $0 (2023) |
| Dexcom, Inc. | $35.23 | 2 | $0 (2022) |
| Allergan Inc. | $33.13 | 3 | $0 (2017) |
| Amarin Pharma Inc. | $19.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.71 | 5 | PFIZER INC. ($35.78) |
| 2023 | $75.49 | 4 | PFIZER INC. ($36.91) |
| 2022 | $89.01 | 5 | Novo Nordisk Inc ($24.19) |
| 2021 | $117.61 | 7 | AbbVie Inc. ($38.12) |
| 2020 | $12.73 | 1 | Merck Sharp & Dohme Corporation ($12.73) |
| 2019 | $12.56 | 1 | Novo Nordisk Inc ($12.56) |
| 2018 | $94.13 | 7 | Merck Sharp & Dohme Corporation ($36.87) |
| 2017 | $132.14 | 10 | SANOFI-AVENTIS U.S. LLC ($58.79) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: PAIN | ||||||
| 07/26/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: VACCINES | ||||||
| 06/30/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VACCINES | ||||||
| 06/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: NEUROLOGY | ||||||
| 04/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: VACCINES | ||||||
| 10/18/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/23/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.19 | General |
| 08/11/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: VACCINES | ||||||
| 05/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: PRIMARY CARE | ||||||
| 03/02/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Endocrinology | ||||||
| 12/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: VACCINE | ||||||
| 06/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiovascular | ||||||
| 05/25/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
| 02/02/2021 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VACCINE | ||||||
| 01/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: VACCINE | ||||||
| 01/02/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Diabetes | ||||||
| 11/15/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 648 | 947 | $99,720 | $48,854 |
| 2022 | 19 | 942 | 1,431 | $138,634 | $70,158 |
| 2021 | 20 | 939 | 1,438 | $128,896 | $63,166 |
| 2020 | 18 | 818 | 1,161 | $119,964 | $55,051 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 259 | $48,174 | $20,235 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $14,508 | $9,303 | 64.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $8,000 | $5,629 | 70.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 73 | $9,052 | $4,026 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 25 | $6,300 | $2,357 | 37.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,660 | $2,227 | 60.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 87 | 87 | $2,175 | $1,448 | 66.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 82 | 82 | $2,870 | $1,364 | 47.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 21 | 21 | $735.00 | $703.29 | 95.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $559.37 | $548.18 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $371.44 | $364.04 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 33 | $1,023 | $303.92 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 21 | $315.00 | $176.40 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $492.00 | $115.39 | 23.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 19 | $285.00 | $39.76 | 14.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 160 | $1,200 | $14.03 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 257 | $47,802 | $21,074 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 199 | $24,676 | $11,609 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $16,926 | $11,126 | 65.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 58 | 162 | $6,804 | $4,987 | 73.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $6,800 | $4,730 | 69.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 41 | $10,332 | $4,573 | 44.3% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 26 | 27 | $5,400 | $3,651 | 67.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,436 | $2,305 | 31.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 50 | 52 | $1,820 | $1,554 | 85.4% |
About Dr. Mitchell Pullias, MD
Dr. Mitchell Pullias, MD is a Internal Medicine healthcare provider based in Smyrna, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215926860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Pullias, MD has received a total of $641.38 in payments from pharmaceutical and medical device companies, with $107.71 received in 2024. These payments were reported across 40 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($641.38).
As a Medicare-enrolled provider, Pullias has provided services to 3,347 Medicare beneficiaries, totaling 4,977 services with total Medicare billing of $237,229. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Smyrna, TN
- Active Since 10/17/2005
- Last Updated 01/02/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215926860
Products in Payments
- TOUJEO (Drug) $78.21
- UBRELVY (Drug) $60.09
- INSPIRE (Device) $53.82
- Ozempic (Drug) $44.72
- SHINGRIX (Biological) $41.81
- NURTEC ODT (Drug) $39.57
- COMIRNATY (Biological) $36.91
- JANUVIA (Drug) $36.87
- ELIQUIS (Drug) $28.89
- Vascepa (Drug) $19.82
- DEXCOM G6 TRANSMITTER (Device) $18.19
- Dexcom G6 Transmitter (Medical Supply) $17.04
- ADVANTAGE FIT SYSTEM (Device) $14.93
- SOLIQUA 100/33 (Biological) $14.61
- PNEUMOVAX 23 (Biological) $14.54
- GARDASIL 9 (Biological) $14.48
- APTIMA COMBO 2 (Device) $12.73
- ROTATEQ (Biological) $12.73
- PREVNAR - 13 (Biological) $12.37
- XARELTO (Drug) $11.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Smyrna
Michael Gibson, M.d, M.D
Internal Medicine — Payments: $2.0M
Hammad Aziz, M.d, M.D
Internal Medicine — Payments: $13,225
Mr. Islam Al Junaidi, Md, MD
Internal Medicine — Payments: $10,247
Dr. Sara Owen, Md, MD
Internal Medicine — Payments: $7,990
Michaele Brown, M.d, M.D
Internal Medicine — Payments: $6,002
Dr. Matthew Perkins, Md, MD
Internal Medicine — Payments: $5,240